| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 03/18/2009 | EP2036911A1 Process for production of aminated phosphoric acid ester compound, flame-retardant resin, and flame-retardant resin composition |
| 03/18/2009 | EP2035367A1 Ship 1 modulator prodrugs |
| 03/18/2009 | EP1663987B1 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2009 | EP1456176B1 Improved compounds for generating chemiluminescence with a peroxidase |
| 03/18/2009 | EP1431302B1 Process for synthesis of organometallic compounds |
| 03/18/2009 | CN101386674A Dendritic poly (propyleneimine)-phosphazene catalyst and preparation and application thereof |
| 03/18/2009 | CN101386628A Hydroxylethylidene diphosphonic acid with arsenic content <=3ppm and preparation technique thereof |
| 03/18/2009 | CN101386627A Process for preparing glyphosate by catalytic oxidation of N-phosphonomethyliminodiacetic acid |
| 03/18/2009 | CN100469788C 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives |
| 03/18/2009 | CN100469781C Technetium-99m marked double phospho acid compound |
| 03/18/2009 | CN100469749C Process and catalyst for dehydrogenating primary alcohols to make carboxylate |
| 03/17/2009 | US7504534 Reaction systems for making N-(phosphonomethyl) glycine compounds |
| 03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
| 03/17/2009 | US7504389 Protein tyrosine phosphatase inhibitors and methods of use thereof |
| 03/17/2009 | US7504388 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 03/17/2009 | US7504088 Lipophilic derivatives of chelate monoamides |
| 03/17/2009 | CA2311925C Method for producing dialkylphosphinic acid salts |
| 03/17/2009 | CA2311675C Method for producing salts of dialkylphosphinic acids |
| 03/12/2009 | WO2009033130A1 Mitochondrial compositions and uses thereof |
| 03/12/2009 | WO2009033054A1 Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | WO2009032180A1 Phosphadiazine hcv polymerase inhibitors iv |
| 03/12/2009 | WO2009032179A1 Phosphadiazine hcv polymerase inhibitors iii and vi |
| 03/12/2009 | WO2009032177A1 Phosphadiazine hcv polymerase inhibitors i and ii |
| 03/12/2009 | WO2009032176A1 Phosphadiazine hcv polymerase inhibitors v |
| 03/12/2009 | WO2009030626A1 New phosphine-phosphite ligands |
| 03/12/2009 | WO2007134107A3 Cold menthol receptor-1 antagonists |
| 03/12/2009 | US20090069598 Solid and crystalline ibandronic acid |
| 03/12/2009 | US20090069568 anti-tumor activity, protein kinase inhibitory activity |
| 03/12/2009 | US20090069563 Rosuvastatin intermediates and their preparation |
| 03/12/2009 | US20090069517 Ligands and catalyst systems for the oligomerization of olefinic monomers |
| 03/12/2009 | US20090069280 17-amino analogs of geldanamycin, used for treating and modulating disorders associated with hyperproliferation, such as cancer; antiproliferative and anticarcinogenic agents |
| 03/12/2009 | US20090069273 Phosphorylated pyrone analogs and methods |
| 03/12/2009 | US20090069272 Composition for treating bone disorders |
| 03/12/2009 | US20090069268 Novel phosphoramidate compounds and methods of use |
| 03/12/2009 | US20090069263 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof |
| 03/12/2009 | US20090068697 Compounds and methods of use thereof for assaying lysophospholipase D activity |
| 03/12/2009 | US20090068543 Phosphorous containing benzoxazine-based monomer, polymer thererof, electrode for fuel cell including the same, electrolyte membrane for fuel cell including the same, and fuel cell employing the same |
| 03/12/2009 | DE102007042154A1 Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel Arylsulfonylaminomethyphosphonsäure derivatives, their preparation and their use as medicaments |
| 03/12/2009 | CA2703831A1 Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | CA2698755A1 Mitochondrial compositions and uses thereof |
| 03/12/2009 | CA2697546A1 Phosphadiazine hcv polymerase inhibitors iv |
| 03/11/2009 | EP2033964A2 Corrosion inhibitor |
| 03/11/2009 | EP2033948A1 Process for preparing Estrogen-antagonistic 11beta-Fluoro-17alpha-alkylestra-1,3,5 (10)-triene-3, 17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and processes for their preparation |
| 03/11/2009 | EP2032641A2 Phosphonium salts for polymer composites and their preparation |
| 03/11/2009 | EP2032589A1 Solvent system for the preparation of n-alkyl thiophosphoric triamide solutions, composition containing n-alkyl thiophosphoric triamide and the use thereof |
| 03/11/2009 | EP2032587A2 Rosuvastatin intermediates and process for the preparation of rosuvastatin |
| 03/11/2009 | EP2032586A2 A process for preparing intermediates of hmg-coa reductase inhibitors |
| 03/11/2009 | EP1567533B1 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
| 03/11/2009 | EP1471921B1 Counteracting bioprosthetic calcification |
| 03/11/2009 | EP1109779B1 Novel mercaptans and disulfides |
| 03/11/2009 | EP0976722B1 Benzamidine derivatives |
| 03/11/2009 | CN101384566A Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists |
| 03/11/2009 | CN101381379A Kinase inhibitor phosphonate conjugates |
| 03/11/2009 | CN101381378A Zirconium glyphosate, preparation method and use thereof |
| 03/11/2009 | CN101381377A Preparation technology suitable for electronic grade solid hexamethylenediamine tetramethylene phosphonic acid |
| 03/11/2009 | CN101381376A Preparation technology suitable for electronic grade solid ethylenediamine tetramethylene phosphonic acid |
| 03/11/2009 | CN101381375A Preparation method of Tri-iso-butyl phosphate |
| 03/11/2009 | CN101381286A Method for synthesizing triphenylphosphine onium salts and halomethyl benzyl ethers compounds |
| 03/11/2009 | CN100467479C Phosphine-phosphoramidite ligand, its preparation method and uses |
| 03/11/2009 | CN100467478C Thiophosphate or phosphate derivative and its preparation and application |
| 03/11/2009 | CN100467477C Process for the preparation of n-substituted n-(phosphonomethyl)glycine |
| 03/11/2009 | CN100467476C Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/11/2009 | CN100467448C Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 03/11/2009 | CA2638354A1 Association of an anti-atherothrombotic and an angiotensin converting enzyme inhibitor |
| 03/10/2009 | US7501542 Highly-packed polycationic ammonium, sulfonium and phosphonium lipids |
| 03/10/2009 | US7501533 selectively monoacylating glycerophosphorylcholine at position sn-1 with an acylating agent( palmitoyl chloride, stearoyl chloride or oleoyl chloride) in presence of dialkyl tin oxide (dioctyl tin oxide) a prefered acylating catalyst and a base triethylamine or 4-dimethylaminopyridine forming monoester |
| 03/10/2009 | US7501522 1-ethyl-3-methylimidazolium chloride mixed with potassium tert-butoxide forming 1-ethyl-3-methylimidazol-2-ylidene, which has been distilled off is brought into contact in the gaseous state with the protic acid |
| 03/10/2009 | US7501505 1,1-Dioxo-1,2-dihydro-1 lambda 6-benzo[d]isothiazol-3-one will promote condensation of a nucleoside phosphoramidite and nucleoside monomer or a nascent oligonucleotide; genetic disorder diagnosis; gene expression inhibitors; treating cytomegalo virus; industrial scale |
| 03/10/2009 | US7501480 low temperature curable monomer selected from a reaction product of 3-isocyanatopropyltriethoxysilane and glycidol, isophorone diisocyanate and bis(3-triethoxysilylpropyl)amine; curing; molding materials, especially optical moldings, coatings, self-supporting films; chemical and wear resistance |
| 03/10/2009 | US7501251 DNA diagnostics based on mass spectrometry |
| 03/10/2009 | CA2358436C Polyunsaturated fatty acid derivatives and their use |
| 03/05/2009 | WO2009029844A1 Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods |
| 03/05/2009 | WO2009029539A1 Mixtures and catalyst systems including transition metal-containing catalysts and noble metal-containing catalysts, processes for their preparation, and processes for their use in oxidation reactions |
| 03/05/2009 | WO2009028707A1 Inhibitor of ischemic disorders |
| 03/05/2009 | WO2009028478A1 Phthalocyanine compound |
| 03/05/2009 | WO2009027729A1 Paracyclophane-based ligands, their preparation and use in catalysis |
| 03/05/2009 | WO2009027692A2 A new method for making krill meal |
| 03/05/2009 | WO2009027108A1 PROCESS FOR PREPARING ESTROGEN-ANTAGONISTIC 11 β-FLUORO-17α-ALKYLESTRA-1,3,5(10)-TRIENE-3,17-DIOLS HAVING A 7α-(ξ-ALKYLAMINO-ω-PERFLUOROALKYL)ALKYL SIDE CHAIN AND α-ALKYL(AMINO)-ω-PERFLUORO(ALKYL)ALKANES AND PROCESSES FOR THEIR PREPARATION |
| 03/05/2009 | WO2009010693A3 Improved process for preparing alkoxyamines resulting from beta-phosphorated nitroxides |
| 03/05/2009 | US20090062568 Process for preparing phosphonates having alcoholic hydroxyl group |
| 03/05/2009 | US20090062558 Process for preparing Estrogen-antagonistic 11 beta-Fluoro-17alpha-alkylestra-1,3,5(10)-triene-3,17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and Processes for their Preparation |
| 03/05/2009 | US20090062554 Process for preparing phosphorus compounds having phosphate-phosphonate bond |
| 03/05/2009 | US20090062493 simultaneous trimerization and tetramerization of ethylene, with a high selectivity for both 1-hexene and 1-octene within the C6 and C8 fractions; Ligand has structure 2(O-)P-P(=N) where oxygens are linked to form a ring such as 1,3,2-benzodioxaphosphole |
| 03/05/2009 | US20090062460 Curing accelerating compound-silica composite material, method for producing curing accelerating compound-silica composite material, curing accelerator, curable resin composition, and electronic component device |
| 03/05/2009 | US20090062436 Aromatic Phosphate Acid Flame Retardant Compositions |
| 03/05/2009 | US20090062250 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability |
| 03/05/2009 | US20090060872 Phosphadiazine hcv polymerase inhibitors v |
| 03/05/2009 | US20090060867 Phosphadiazine hcv polymerase inhibitors iii and vi |
| 03/05/2009 | US20090060866 Phosphadiazine hcv polymerase inhibitors i and ii |
| 03/05/2009 | US20090060837 Cobalamin conjugates useful as antitumor agents |
| 03/05/2009 | US20090058289 Materials for Organic Electroluminescent Devices |
| 03/05/2009 | DE102007040247A1 Korrosionsinhibitor Corrosion inhibitor |
| 03/05/2009 | CA2698094A1 Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods |
| 03/05/2009 | CA2697900A1 Inhibitor of ischemic disorders |
| 03/05/2009 | CA2697730A1 A new method for making krill meal |
| 03/05/2009 | CA2697713A1 Process for preparing estrogen-antagonistic 11 .beta.-fluoro-17.alpha.-alkylestra-1,3,5(10)-triene-3,17-diols having a 7.alpha.-(.xi.-alkylamino-.omega.-perfluoroalkyl)alkyl side chain and .alpha.-alkyl(amino)-.omega.-perfluoro(alkyl)alkanes and processes for their preparation |
| 03/04/2009 | EP2030978A1 Phosphine transition metal complex, method for producing the same and antitumor agent |
| 03/04/2009 | EP2029626A2 Immune-derived moieties reactive against lysophosphatidic acid |
| 03/04/2009 | EP2029614A2 Cold menthol receptor-1 antagonists |